FDA Inspection 1089435 — ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc. — FEI 2111358

The FDA completed an inspection of ANI Pharmaceuticals, Inc. on Apr 12, 2019 in Baudette, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Apr 12, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Baudette, MN (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.